Načítá se...
Designing tuberculosis vaccine efficacy trials – lessons from recent studies
Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or strategies have advanced into clinical efficacy tr...
Uloženo v:
| Vydáno v: | Expert Rev Vaccines |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492041/ https://ncbi.nlm.nih.gov/pubmed/30892969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2019.1593143 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|